AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER

Health Canada approves two GSK drugs for metastatic melanoma

 health canada, Uncategorized  Comments Off on Health Canada approves two GSK drugs for metastatic melanoma
Jul 262013
 

Image Placeholder

Health Canada has approved two GlaxoSmithKline (GSK) drugs, Tafinlar(TM) (dabrafenib mesilate) and Mekinist(TM) (trametinib), for patients with unresectable or metastatic melanoma. Dabrafenib mesylate, which is a BRAF-inhibitor, is indicated as a monotherapy oral treatment for unresectable melanoma or metastatic melanoma in adult …http://www.gsk.ca/english/html/media-centre/2013-07-24.html

Share
Jul 052013
 

Fibristal (ulipristal acetate)

Health Canada grants marketing approval for Actavis’ Fibristal to treat uterine fibroids
Health Canada has granted marketing approval for Actavis’ Fibristal (ulipristal acetate) to treat symptoms of uterine fibroids in adult women of reproductive age who are eligible for surgery…

 

http://regulatoryaffairs.pharmaceutical-business-review.com/news/health-canada-grants-marketing-approval-for-actavis-fibristal-to-treat-uterine-fibroids-260613

Share
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: